Sand Hill Angels

Aligned Carbon Inc. is a manufacturer of carbon nanotubes (CNTs) specifically designed for the integrated circuit industry. Established in 2018 and headquartered in Santa Clara, California, the company produces semiconductor-pure, aligned CNTs that are available on industry-standard wafers at a manufacturing scale. These CNTs are uniquely aligned in arrays that cover full semiconductor substrates and can be purified to be either entirely semiconducting or metallic. Aligned Carbon's technology facilitates a transition away from traditional silicon, allowing semiconductor foundries to achieve significant improvements in speed, energy efficiency, and performance in applications such as logic processing, signal processing, and advanced sensing technologies. The company's innovations enable clients to enhance computing applications through the integration of carbon nanotube logic with conventional silicon logic and memory, thereby addressing growing demands in the semiconductor sector.

Founded in 2016, Bionaut Labs specializes in developing intra-tissue navigation platforms using micro-robots for precise anatomical targeting. Its innovative technology enables remote-controlled delivery of therapeutics to challenging clinical settings, revolutionizing the treatment of central nervous system disorders and other diseases.

Nanochon is developing an implantable, 3D-printed cartilage implant designed to replace damaged cartilage and promote new tissue growth in joints, with a focus on knee damage. The device combines 3D printing and a novel nanomaterial to enable on-demand, cost-effective solutions intended to restore joint function and improve outcomes for young and active patients.

Aligned Carbon Inc. is a manufacturer of carbon nanotubes (CNTs) specifically designed for the integrated circuit industry. Established in 2018 and headquartered in Santa Clara, California, the company produces semiconductor-pure, aligned CNTs that are available on industry-standard wafers at a manufacturing scale. These CNTs are uniquely aligned in arrays that cover full semiconductor substrates and can be purified to be either entirely semiconducting or metallic. Aligned Carbon's technology facilitates a transition away from traditional silicon, allowing semiconductor foundries to achieve significant improvements in speed, energy efficiency, and performance in applications such as logic processing, signal processing, and advanced sensing technologies. The company's innovations enable clients to enhance computing applications through the integration of carbon nanotube logic with conventional silicon logic and memory, thereby addressing growing demands in the semiconductor sector.

Founded in 2018, NS Nanotech specializes in developing nano-LED technology for various applications. Their patented nitride semiconductors emit light in the visible RGB spectrum for display technologies and in the invisible UV spectrum for far-UVC disinfection. This enables safer, more efficient, and environmentally friendly solutions compared to traditional germicidal UVC lamps.

Molekule develops advanced air purifiers using proprietary PECO technology to destroy pollutants at the molecular level, including viruses and VOCs. Serving customers in the US and Canada, Molekule offers products like Air, Air Mini+, Air Mini, and Air Pro RX for various room sizes and medical use.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Founded in 2018, NS Nanotech specializes in developing nano-LED technology for various applications. Their patented nitride semiconductors emit light in the visible RGB spectrum for display technologies and in the invisible UV spectrum for far-UVC disinfection. This enables safer, more efficient, and environmentally friendly solutions compared to traditional germicidal UVC lamps.

BotFactory develops and manufactures desktop electronic circuit printers. Its flagship product, Squink, enables users to design and create 3D printed electronic prototypes using print conductive ink, dispense solder paste or glue, and pick and place components. BotFactory serves Fortune 500 research labs, aerospace companies, universities, and electronics makers, accelerating their prototyping processes.

BotFactory develops and manufactures desktop electronic circuit printers. Its flagship product, Squink, enables users to design and create 3D printed electronic prototypes using print conductive ink, dispense solder paste or glue, and pick and place components. BotFactory serves Fortune 500 research labs, aerospace companies, universities, and electronics makers, accelerating their prototyping processes.

BotFactory develops and manufactures desktop electronic circuit printers. Its flagship product, Squink, enables users to design and create 3D printed electronic prototypes using print conductive ink, dispense solder paste or glue, and pick and place components. BotFactory serves Fortune 500 research labs, aerospace companies, universities, and electronics makers, accelerating their prototyping processes.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Nanotech Biomachines specializes in advanced sensor technology aimed at transforming therapeutic discovery and development. The company leverages modern electronic materials and straightforward membrane preparations to achieve high sensitivity and specificity in measuring real-time binding to integral membrane proteins (IMPs). This innovative approach is mass-independent, cell-free, and label-free, allowing for direct electronic output using native IMPs in fluid membranes. By providing clients with this cutting-edge sensor technology, Nanotech Biomachines enhances the efficiency and effectiveness of the drug discovery process, positioning itself at the forefront of 21st-century medicine development.

Nanomed is a provider of graphene biosensor products used in life science research, drug discovery, and diagnostics, and health-monitoring. They provide fast and affordable tools for small molecule drug discovery. They have developed a breakthrough electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions. This technology employs a unique graphene biosensor to enable label-free, highly sensitive binding studies of small molecules to proteins. With a wide dynamic range, small sample requirements, and minimal signal contributions from common solvents and detergents, their technology complements existing technology and accelerates small molecule drug discovery. As the world’s leading mass-manufacturer of next-generation graphene biosensors, their mission is to transform the healthcare industry with innovative new products that accelerate cutting-edge life science and drug discovery research. It was founded in 2013 and is based in San Diego, California.

Nanotech Biomachines specializes in advanced sensor technology aimed at transforming therapeutic discovery and development. The company leverages modern electronic materials and straightforward membrane preparations to achieve high sensitivity and specificity in measuring real-time binding to integral membrane proteins (IMPs). This innovative approach is mass-independent, cell-free, and label-free, allowing for direct electronic output using native IMPs in fluid membranes. By providing clients with this cutting-edge sensor technology, Nanotech Biomachines enhances the efficiency and effectiveness of the drug discovery process, positioning itself at the forefront of 21st-century medicine development.

Agoura Technologies, Inc., a nanotechnology company, develops optical films.